NCT07437287
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07437287
Title Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers (CROCOBIL)
Acronym CROCOBIL
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de cancérologie de l'Ouest - Site Paul Papin Angers 49933 France Details
CHU de Bordeaux - Hopital Haut Leveque Bordeaux France Details
CHU Brest Brest France Details
Centre François Baclesse Caen France Details
CHU Estaing Clermont-Ferrand France Details
CHU de Dijon Dijon France Details
CHU Grenoble Alpes Grenoble France Details
CHU Lille Lille France Details
Centre Léon Bérard Lyon France Details
CHU de Lyon Lyon France Details
APHM - CHU La Timone Marseille France Details
CHU Montpellier - Hôpital Saint Eloi Montpellier France Details
CHU Hotel Dieu Nantes France Details
Hopital du Confluent Nantes France Details
APHP - Hopital Beaujon Paris France Details
Institut Curie Paris France Details
CHU Poitiers Poitiers France Details
Institut Jean Godinot Reims France Details
Centre Eugène Marquis Rennes France Details
Centre Paul Strauss Strasbourg France Details
CHU Tours Tours France Details
Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field